NAP-2 (CXCL7)
Neutrophil Activating Peptide 2 (NAP2), Connective Tissue Activating Protein III (CTAPIII) and βthrombogulin (βTG), are proteolytically processed carboxylterminal fragments of platelet basic protein (PBP) which is found in the alphagranules of human platelets. NAP2 is a member of the CXC chemokines. Similar to other ELR domain containing CXC chemokines such as IL8 and the GRO proteins, NAP2 has been shown to bind CXCR2 and to chemoattract and activate neutrophils. Although CTAPIII, βTG and PBP represent aminoterminal extended variants of NAP 2 and possess the same CXC chemokine domains, these proteins do not exhibit NAP2 activity. It has been shown that the additional aminoterminal residues of CTAP III masks the critical ELR receptor binding domain that is exposed on NAP2 and may account for lack of NAP2 activity.
Product Specifications
Synonyms
CXCL7, NAP1L4; NAP2; NAP2L; hNAP2; NAP1L4b
NCBI Gene ID
5473
UniProt
P02775
Accession Number
NP_002695.1
Accession Number mRNA
NM_002704.3
Chromosomal Location
5 E1; 5
Reactivity
Anti-Human
Cross Reactivity
Human
Target Antigen
Recombinant Human NAP-2
Clone
Goat IgG
Applications
ELISA, WB
Purification Method
Antigen-affinity purified
Assay Protocol
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
Form
Lyophilized from PBS
Buffer
PBS
Reconstitution
Water
Storage Conditions
Host or Source
Goat
Explore Other Products
Browse additional items from our catalog